The Impact of a Topical Vasodilating Cream on Female Sexual Experience (TVConFSD)

This study is currently recruiting participants.

Verified March 2012 by East Suburban Ob Gyn

Sponsor:

Collaborator:

West Penn Allegheny Health System

Information provided by (Responsible Party):

Michael Pelekanos MD, East Suburban Ob Gyn

ClinicalTrials.gov Identifier:

NCT01078077

First received: March 1, 2010

Last updated: March 1, 2012

Last verified: March 2012

History of Changes

Purpose

The purpose of this study is to determine if a topical vasodilating cream will improve female sexual experience.

Condition
Female Sexual Dysfunction

Study Type:	Observational
Study Design:	Observational Model: Case Control Time Perspective: Prospective
Official Title:	The Impact of a Topical Vasodilating Cream (When Applied to the Clitoris) on the Female Sexual Experience Using a Standard 7 Part Female Sexual Dysfunction Questionnaire

Further study details as provided by East Suburban Ob Gyn:

Estimated Enrollment:	200
Study Start Date:	March 2010
Estimated Study Completion Date:	July 2012
Primary Completion Date:	March 2012 (Final data collection date for primary outcome measure)

Detailed Description:

To determine in a placebo controlled double blinded study whether a topically applied vasodilating cream will improve the female sexual response as measured by a standard female sexual dysfunction questionnaire

Eligibility

Ages Eligible for Study:	25 Years to 60 Years
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	Yes
Sampling Method:	Non-Probability Sample

Study Population

Sexually active females from ages 25 to sixty not on SSRI's without neurologic disease able sign and understand informed consent

Criteria

Inclusion Criteria:

Healthy females ages 25 to sixty sexually active

Exclusion Criteria:

Neurologic disease, on SSRI's,advanced diabetes, non sexually active, mentally incompetent

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT01078077

Contacts

Contact: michael j pelekanos, MD	4128567500	mipels@aol.com
Contact: Guy Stofman, MD	4123706313	guystof@aol.com

Locations

United States, Pennsylvania
West Penn Allegheny Health Center	Recruiting
Monroeville, Pennsylvania, United States, 15146
Contact: pelekanos 412-856-7500
Contact: vickie lathom 4128567500
Principal Investigator: michael j pelekanos, md
West Penn Hospital Forbes Campus	Recruiting
Monroeville, Pennsylvania, United States, 15146
Contact: michael j pelekanos, md 412-856-7500 mipels@aol.com
Principal Investigator: michael j pelekanos, md
East Suburban Obgyn	Recruiting
Monroeville, Pennsylvania, United States, 15146
Contact: Michael J Pelekanos, MD 412-779-1034 mipels@aol.com
Contact: Guy Stoffman, MD 412 3706313 guystof@aol.com
Principal Investigator: Michael J Pelekanos, MD

Sponsors and Collaborators

Michael Pelekanos MD

West Penn Allegheny Health System

Investigators

Principal Investigator:

michael j pelekanos, MD

east surburban obgyn

More Information

No publications provided

Responsible Party:	Michael Pelekanos MD, michael pelekanos MD, WPAHS, East Suburban Ob Gyn
ClinicalTrials.gov Identifier:	NCT01078077 History of Changes
Other Study ID Numbers:	10-005
Study First Received:	March 1, 2010
Last Updated:	March 1, 2012
Health Authority:	United States: Institutional Review Board

Keywords provided by East Suburban Ob Gyn:

healthy females ages twentyfive through sixty

Additional relevant MeSH terms:

Sexual Dysfunctions, Psychological
Sexual and Gender Disorders
Mental Disorders

ClinicalTrials.gov processed this record on May 16, 2013

To Top